Repeated low-level red-light therapy for shortening axial length in high myopia children and teenagers:a prospective, single-arm study - Repeated low-level red-light therapy shortens axial length

Ohno Kyoko0 sites30 target enrollmentSeptember 20, 2022

Overview

No summary available.

Registry

who.int

Start Date

September 20, 2022

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Ohno Kyoko

•Provision of consent
•Age 8 years or older and less than or equal to 18 years old or younger at enrollment. High myopia cycloplegic sphere less than or equal to \-6\.00 dioptres in both eyes. Willing and able to participate in all required activities of the study. Normal Fundus , tessellated fundus or with peripapillary diffuse chorioretinal atrophy

•The children undergoing or previously treated with myopia control treatments, eg orthokeratology, low dose atropine eye drops, multifocal soft contact lenses. However, children currently using only low dose atropine eye drops, can be recruited but atropine treatment should be discontinued for at least 2 weeks.
•Secondary myopia, such as a history of retinopathy of prematurity or neonatal problems, or syndromic myopia with a known genetic disease or connective tissue disorders, such as Stickler or Marfan syndrome.
•Pathologic myopia with signs of macula involving diffuse chorioretinal atrophy, patchy chorioretinal atrophy, macular atrophy, lacquer cracks, myopic choroidal neovascularization or Fuchs spots.
•Strabismus and binocular vision abnormalities in either eye.
•Previous Any intraocular surgery affecting refractive status.
•Other reasons, including but not limited to ocular or other systemic abnormalities, that the physician may consider inappropriate for enrollment.